Literature DB >> 12421262

Trend of neonatal group B streptococcal infection during the last 15 years.

Kiyoshi Hoshina1, Yoko Suzuki, Hiroshi Nishida, Kazuhiko Kaneko, Seiji Matsuda, Masumi Kobayashi, Nobuaki Kadoi.   

Abstract

BACKGROUND: The survey was designed to determine the trend of group B streptococcal (GBS) infection during the last 15 years, as well as update the reality of this disease.
METHODS: Questionnaires were administered every 5 years towards neonatal intensive care unit-equipped hospitals. The first survey was made from 1983 to 1987, the second one from 1988 to 1992 and the third one from 1993 to 1997. The 15-year questionnaire survey included a total of 831 patients. The changes in number of patients, the ages at onset, the diagnosis, the serotypes of causative agents, the presence or absence of complicated delivery and the prognosis were analyzed.
RESULTS: It seems that the increasing trend of the number of patients has stopped in the period from 1993 to 1997 (third survey). The most common causative subtype was type III GBS, regardless of early onset type or late onset type. As to perinatal abnormality, approximately 40% of the early onset cases were free from risk factors. Concerning the prognosis, 22.6% of early onset cases and 38.7% of late onset cases died or had sequelae.
CONCLUSIONS: The number of GBS-infected cases has stopped increasing, but it is still necessary to carry out screenings of pregnant women for the purpose of decreasing the onset of the disease.

Entities:  

Mesh:

Year:  2002        PMID: 12421262     DOI: 10.1046/j.1442-200x.2002.01638.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  8 in total

1.  Emergence of invasive serotype VIII group B streptococcal infections in Denmark.

Authors:  Kim Ekelund; Hans-Christian Slotved; Hans Ulrik Nielsen; Margit S Kaltoft; Helle B Konradsen
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

2.  L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.

Authors:  Mioko Fujieda; Youko Aoyagi; Kousaku Matsubara; Yasuhito Takeuchi; Wakae Fujimaki; Misao Matsushita; John F Bohnsack; Shinji Takahashi
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

3.  Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011-2015.

Authors:  Kousaku Matsubara; Kiyoshi Hoshina; Masatoshi Kondo; Isao Miyairi; Yoshiya Yukitake; Yusuke Ito; Kisei Minami; Ryuichi Genkawa
Journal:  Infection       Date:  2017-02-25       Impact factor: 3.553

4.  Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci.

Authors:  Hiroshige Mikamo; Atul K Johri; Lawrence C Paoletti; Lawrence C Madoff; Andrew B Onderdonk
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 5.  Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.

Authors:  Sarah Shabayek; Barbara Spellerberg
Journal:  Front Microbiol       Date:  2018-03-14       Impact factor: 5.640

Review 6.  Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.

Authors:  Fiorella Bianchi-Jassir; Proma Paul; Ka-Ning To; Clara Carreras-Abad; Anna C Seale; Elita Jauneikaite; Shabir A Madhi; Neal J Russell; Jenny Hall; Lola Madrid; Quique Bassat; Gaurav Kwatra; Kirsty Le Doare; Joy E Lawn
Journal:  Vaccine       Date:  2020-09-02       Impact factor: 3.641

7.  Evaluation of chromID strepto B as a screening media for Streptococcus agalactiae.

Authors:  Toyohisa Morita; Dongyun Feng; Yoko Kamio; Isao Kanno; Teruo Somaya; Kazuhito Imai; Misaki Inoue; Mutsunori Fujiwara; Akihito Miyauchi
Journal:  BMC Infect Dis       Date:  2014-01-29       Impact factor: 3.090

Review 8.  Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.

Authors:  Lola Madrid; Anna C Seale; Maya Kohli-Lynch; Karen M Edmond; Joy E Lawn; Paul T Heath; Shabir A Madhi; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Stephanie Schrag
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 20.999

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.